Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features

[1]  J. Lai,et al.  Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1. , 2018, Pathology, research and practice.

[2]  Tsuyoshi Saito,et al.  Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma. , 2018, Human pathology.

[3]  A. Butte,et al.  Comprehensive analysis of normal adjacent to tumor transcriptomes , 2017, Nature Communications.

[4]  N. Denić,et al.  An unusual primary malignant tumor of the stomach: fetal gutlike gastric adenocarcinoma with "blastoma"-like component. , 2017, Human pathology.

[5]  E. Oliva,et al.  Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis , 2017, Journal of Clinical Pathology.

[6]  H. Aburatani,et al.  Gastric Cancer With Primitive Enterocyte Phenotype: An Aggressive Subgroup of Intestinal-type Adenocarcinoma , 2017, The American journal of surgical pathology.

[7]  Yan Lu,et al.  HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway , 2017, International journal of cancer.

[8]  J. Stenvang,et al.  Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer , 2017, BMC Cancer.

[9]  Kol Jia Yong,et al.  Targeting SALL4 by entinostat in lung cancer , 2016, Oncotarget.

[10]  D. Tenen,et al.  SALL4, the missing link between stem cells, development and cancer. , 2016, Gene.

[11]  A. Aggarwal,et al.  Genomic alterations and molecular subtypes of gastric cancers in Asians , 2016, Chinese journal of cancer.

[12]  T. Sun,et al.  Expression of α-fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity. , 2016, Oncology reports.

[13]  Tao Qu,et al.  PRISMA-Compliant Article: Clinical Characteristics and Factors Influencing Prognosis of Patients With Hepatoid Adenocarcinoma of the Stomach in China , 2016, Medicine.

[14]  S. Yao,et al.  Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. , 2016, World journal of gastroenterology.

[15]  Qingsi He,et al.  High level of Serum AFP is an Independent Negative Prognostic Factor in Gastric Cancer , 2015, The International journal of biological markers.

[16]  L. Teng,et al.  Hepatoid adenocarcinoma of the stomach: Nine case reports and treatment outcomes. , 2015, Oncology letters.

[17]  Yoo-Seok Yoon,et al.  SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis , 2015, Journal of pathology and translational medicine.

[18]  Jason G. Jin,et al.  Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes , 2015, Nature Medicine.

[19]  B. Zhang,et al.  SALL4, a novel marker for human gastric carcinogenesis and metastasis , 2014, Oncogene.

[20]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[21]  K. H. Huang,et al.  Clinical manifestations in patients with alpha-fetoprotein-producing gastric cancer. , 2014, Current oncology.

[22]  H. Nielsen,et al.  Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort , 2013, PloS one.

[23]  H. Nielsen,et al.  Assessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer , 2013, Scandinavian journal of gastroenterology.

[24]  W. Sheng,et al.  An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP‐producing gastric cancer , 2012, Journal of surgical oncology.

[25]  V. Rotter,et al.  Amplification of the 20q Chromosomal Arm Occurs Early in Tumorigenic Transformation and May Initiate Cancer , 2011, PloS one.

[26]  W. Sheng,et al.  Analysis of Clinicopathologic Features and Prognostic Factors in Hepatoid Adenocarcinoma of the Stomach , 2010, The American journal of surgical pathology.

[27]  H. Katai,et al.  Long‐term results of gastrectomy for α‐fetoprotein‐producing gastric cancer , 2010, The British journal of surgery.

[28]  M. Fukayama,et al.  SALL4 Represents Fetal Gut Differentiation of Gastric Cancer, and is Diagnostically Useful in Distinguishing Hepatoid Gastric Carcinoma From Hepatocellular Carcinoma , 2010, The American journal of surgical pathology.

[29]  Kenny Q. Ye,et al.  Sensitive and accurate detection of copy number variants using read depth of coverage. , 2009, Genome research.

[30]  K. Butler,et al.  Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization. , 2009, International journal of oncology.

[31]  J. Ritz,et al.  SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. , 2006, Blood.

[32]  Y. Nakanishi,et al.  Genetic evolution of α fetoprotein producing gastric cancer , 2003 .

[33]  T. Motoyama,et al.  Histogenesis of hepatoid adenocarcinoma of the stomach:Molecular evidence of identical origin with coexistent tubular adenocarcinoma , 2003, International journal of cancer.

[34]  Bauke Ylstra,et al.  Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high‐resolution microarray comparative genomic hybridization , 2003, The Journal of pathology.

[35]  S. Hidaka,et al.  Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer. , 2003, Anticancer research.

[36]  Y. Kawarada,et al.  Further evidence of hepatic transdifferentiation in hepatoid adenocarcinomas of the stomach: quantitative analysis of mRNA for albumin and hepatocyte nuclear factor‐4α , 2003, Pathology.

[37]  R S Warren,et al.  Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization , 1999, Genes, chromosomes & cancer.

[38]  H. Ishikura,et al.  An AFP‐producing gastric carcinoma with features of hepatic differentiation. A case report , 1985, Cancer.

[39]  Chen-Ming Hsu,et al.  Clinicopathologial features of gastric hepatoid adenocarcinoma , 2015, Biomedical journal.

[40]  M. Honda,et al.  The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. , 2014, Journal of hepatology.